Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials

OBJECTIVE: Evaluate the effect of upadacitinib on pain outcomes in patients with active psoriatic arthritis (PsA) or ankylosing spondylitis (AS) across 3 randomised trials (SELECT-PsA 1 and 2 for PsA; SELECT-AXIS 1 for AS). METHODS: Patients were randomised to upadacitinib 15 mg once daily or placeb...

Descripción completa

Detalles Bibliográficos
Autores principales: McInnes, Iain B, Ostor, Andrew J K, Mease, Philip J, Tillett, William, Baraliakos, Xenofon, de Vlam, Kurt, Bessette, Louis, Lippe, Ralph, Maniccia, Anna, Feng, Dai, Gao, Tianming, Zueger, Patrick, Saffore, Christopher, Kato, Koji, Song, In-Ho, Deodhar, Atul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Spondyloarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948377/
https://www.ncbi.nlm.nih.gov/pubmed/35332058
http://dx.doi.org/10.1136/rmdopen-2021-002049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948377/
https://www.ncbi.nlm.nih.gov/pubmed/35332058
http://dx.doi.org/10.1136/rmdopen-2021-002049

Ejemplares similares